<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/40C9799D-310C-40D8-BF9F-BCC65A035F0A"><gtr:id>40C9799D-310C-40D8-BF9F-BCC65A035F0A</gtr:id><gtr:name>Philips Healthcare</gtr:name><gtr:address><gtr:line1>The Observatory</gtr:line1><gtr:line2>Castlefield Road</gtr:line2><gtr:postCode>RH2 0FY</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/B32FA032-9DBB-4DEA-9C67-C7274F69B375"><gtr:id>B32FA032-9DBB-4DEA-9C67-C7274F69B375</gtr:id><gtr:name>Division of Imaging Sciences &amp; Biomedical Engineering</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:department>Division of Radiotherapy and Imaging</gtr:department><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/83D87776-5958-42AE-889D-B8AECF16B468"><gtr:id>83D87776-5958-42AE-889D-B8AECF16B468</gtr:id><gtr:name>University of Leeds</gtr:name><gtr:address><gtr:line1>University of Leeds</gtr:line1><gtr:line4>Leeds</gtr:line4><gtr:line5>West Yorkshire</gtr:line5><gtr:postCode>LS2 9JT</gtr:postCode><gtr:region>Yorkshire and The Humber</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3A5E126D-C175-4730-9B7B-E6D8CF447F83"><gtr:id>3A5E126D-C175-4730-9B7B-E6D8CF447F83</gtr:id><gtr:name>University College London</gtr:name><gtr:address><gtr:line1>Gower Street</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>WC1E 6BT</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/40C9799D-310C-40D8-BF9F-BCC65A035F0A"><gtr:id>40C9799D-310C-40D8-BF9F-BCC65A035F0A</gtr:id><gtr:name>Philips Healthcare</gtr:name><gtr:address><gtr:line1>The Observatory</gtr:line1><gtr:line2>Castlefield Road</gtr:line2><gtr:postCode>RH2 0FY</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/B32FA032-9DBB-4DEA-9C67-C7274F69B375"><gtr:id>B32FA032-9DBB-4DEA-9C67-C7274F69B375</gtr:id><gtr:name>Division of Imaging Sciences &amp; Biomedical Engineering</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/87CC2E56-8AAB-46AD-ADCC-E20E83ED3836"><gtr:id>87CC2E56-8AAB-46AD-ADCC-E20E83ED3836</gtr:id><gtr:firstName>Jeffrey</gtr:firstName><gtr:otherNames>Colin</gtr:otherNames><gtr:surname>Bamber</gtr:surname><gtr:orcidId>0000-0001-9436-1832</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/53548EC0-7F9D-454B-99EB-130EA1F68FD3"><gtr:id>53548EC0-7F9D-454B-99EB-130EA1F68FD3</gtr:id><gtr:firstName>Uwe</gtr:firstName><gtr:surname>Oelfke</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/84CBC165-4691-450F-9345-6C226573026C"><gtr:id>84CBC165-4691-450F-9345-6C226573026C</gtr:id><gtr:firstName>Steve</gtr:firstName><gtr:surname>Webb</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/0275454D-4FEC-4FDE-8A13-6ED31A4D624A"><gtr:id>0275454D-4FEC-4FDE-8A13-6ED31A4D624A</gtr:id><gtr:firstName>Philip</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/43B575F0-8764-4AAF-B842-B09F0D8ED177"><gtr:id>43B575F0-8764-4AAF-B842-B09F0D8ED177</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:otherNames>Osmund</gtr:otherNames><gtr:surname>Leach</gtr:surname><gtr:orcidId>0000-0002-0756-5368</gtr:orcidId><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/DD07B141-55DB-4956-8F36-F6928D125EDD"><gtr:id>DD07B141-55DB-4956-8F36-F6928D125EDD</gtr:id><gtr:firstName>Gail</gtr:firstName><gtr:otherNames>Reinette</gtr:otherNames><gtr:surname>ter Haar</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=EP%2FH046526%2F1"><gtr:id>E5C7F40B-B241-4D4A-88A3-5C392CCA8953</gtr:id><gtr:title>Multimodality Techniques for Cancer Diagnosis and Therapy</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/H046526/1</gtr:grantReference><gtr:abstractText>Many of the key opportunities that currently exist for improving the diagnosis and treatment of cancer are cross-disciplinary. Imaging now crucially underpins all therapeutic procedures. The Joint Department of Physics has developed and implemented methods for accurately delivering different radiation therapies to tumours using CT, Magnetic Resonance (MR) and/or ultrasound (US) imaging, but the use of emerging molecular imaging techniques (such as Positron Emission Tomography (PET), functional MR, US and optoacoustic imaging) will give us the opportunity to define targets according to biochemical or metabolic function. A major challenge in therapeutics is organ motion: here, for example, we are developing methods for pre-treatment modelling using MR, real-time US and intelligent x-ray tracking to guide radio- and US therapy. There are significant challenges in developing cross-disciplinary projects. These include training and retention of staff with the key combination of skills in imaging physics, therapy and clinical application, and the development of specialist multi-modality equipment, molecular imaging probes and histological techniques to support pilot studies. For example, satisfying the needs of both x-ray imaging and MR compatibility, can be challenging. A particular challenge in this sector is the translation of laboratory research to a stage where it may be tested in clinical trials. We are uniquely placed for addressing these. Platform funding will help us to retain researchers with the highly specialist key skills, to fund the pilot work for multi-modality applications and to allow translation of research results to a stage where they are ready for exploitation either in our clinics or by collaboration with industry.</gtr:abstractText><gtr:potentialImpactText>The beneficiaries of the work proposed under this Platform Grant will be cancer patients, their carers and relatives, and the Healthcare Sector: both the UK National Heath Service (NHS) and a range of companies within the biomedical and pharmaceutical industries. Our research groups at The Institute of Cancer Research are based within, and work in close collaboration with, the Royal Marsden NHS Foundation Trust (RMH). They are thus ideally placed to translate laboratory research to a stage where it may be tested in clinical trials by the NHS. The platform funding requested is to be used in large part to meet this challenge, by funding pilot work and by helping us to retain researchers with the highly specialist key skills required. This funding is often very hard to find via traditional project grants. The direct beneficiaries of this work will clearly be cancer patients, with the NHS benefiting from the use of new improved technologies and more efficient diagnosis and treatment. The major beneficiaries of the proposed work, which crosses traditional boundaries between imaging and treatment modalities, will initially be industrial partners and collaborators, who will develop and market the next generation of instrumentation and pharmaceuticals arising from these innovative projects. This will in turn provide the means for dissemination of the technologies to other hospitals, permitting more extensive clinical trials and applications, increasing the benefit to patients, carers, relatives and the NHS. We will use platform funding to strengthen our international and national academic and university/hospital collaborations by short-term exchange of personnel to obtain and disseminate leading-edge expertise. We have an established track record of working with industry, from early-stage research through sponsored studentships and collaborative research agreements, beta-testing and first clinical evaluation of new equipment, to licensing of intellectual property and technology transfer. Team leaders will continue to take the lead in developing and maintaining appropriate industrial collaborations. This will often take place in partnership with the RMH, for example in the development and clinical testing of state-of-the-art clinical equipment. Collaborative research agreements, IP protection and technology transfer are managed by the Institute's Enterprise Unit, which again has a proven track record of working with companies of all sizes, and setting up our own spin-out companies. The Institute of Cancer Research has a commitment to the widest dissemination of its research results, both in the scientific literature, and to the general public. Our annual report and annual departmental research reports are published on our public web site. Direct communication with cancer patients is most appropriately managed in partnership with the NHS and charitable research funding organisations such as CRUK. We will continue to disseminate our results to the general public through the Institute's Interactive Education Unit and the professional science writers within the Institute's Press Office. Younger staff members are encouraged and supported to become science ambassadors in local schools and our Department will continue to host visits from local school 6th forms, presenting education both about cancer and about career opportunities in research and in the NHS. Platform funding with help us to continue with this work. PhD students and post-doctoral fellows will be given the opportunity to attend science communication courses organised in-house using national experts. Provision of trained personnel to the NHS and industry is another of our Institute's major contributions. Finally, many of our senior staff are actively engaged in national and international consultative, policy-making and standard-setting committees.</gtr:potentialImpactText><gtr:fund><gtr:end>2015-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1400150</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London (ICL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Imperial College Trust</gtr:department><gtr:description>Vascular occlusion collaboration</gtr:description><gtr:id>1ED6DA72-CFA2-4265-B311-D28B41355A93</gtr:id><gtr:impact>Conference presentations at ISTU 2015, ISUOG 2015
Paper submitted to Science Translational Medicine
Outline followup grant application to MRC accepted</gtr:impact><gtr:partnerContribution>Imperial provided fetal medicine expertise
Cambridge provided experimental facilities and physiology expertise</gtr:partnerContribution><gtr:piContribution>Provided HIFU vascular occlusion expertise, input into experiments, publications, and conference presentations</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Division of Imaging Sciences &amp; Biomedical Engineering</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Biomedical Engineering</gtr:department><gtr:description>THIFU collaboration</gtr:description><gtr:id>CF7C1B7B-5224-46B3-B5ED-1F6CDC694341</gtr:id><gtr:impact>Publications, conference presentations, further collaborations.</gtr:impact><gtr:partnerContribution>UCL were the PIs on the grant</gtr:partnerContribution><gtr:piContribution>EPSRC funded collaborative 5 year program grant employing 3 staff at ICR plus Co-I</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL Mechanical Engineering</gtr:department><gtr:description>THIFU collaboration</gtr:description><gtr:id>B3CAED88-9BC0-40AA-BCE8-87C18078AB54</gtr:id><gtr:impact>Publications, conference presentations, further collaborations.</gtr:impact><gtr:partnerContribution>UCL were the PIs on the grant</gtr:partnerContribution><gtr:piContribution>EPSRC funded collaborative 5 year program grant employing 3 staff at ICR plus Co-I</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Physiology, Development and Neuroscience</gtr:department><gtr:description>Vascular occlusion collaboration</gtr:description><gtr:id>D2761120-C7E6-4656-9A82-F370DFF4FA14</gtr:id><gtr:impact>Conference presentations at ISTU 2015, ISUOG 2015
Paper submitted to Science Translational Medicine
Outline followup grant application to MRC accepted</gtr:impact><gtr:partnerContribution>Imperial provided fetal medicine expertise
Cambridge provided experimental facilities and physiology expertise</gtr:partnerContribution><gtr:piContribution>Provided HIFU vascular occlusion expertise, input into experiments, publications, and conference presentations</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Philips Healthcare</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:description>Philips</gtr:description><gtr:id>C9AEDEA4-EDA0-411E-B401-D8396067957A</gtr:id><gtr:impact>Collaboration is multi-disciplinary, involving Physics, engineering &amp;amp; clinical medicine</gtr:impact><gtr:partnerContribution>Philips have provided the Sonalleve system, and sponsored the clinical trial. They are also funding a PhD student</gtr:partnerContribution><gtr:piContribution>Working with Philips on HIFU research, and to test their Sonalleve HIFU system in the clinic.</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Leeds Microbubbles</gtr:description><gtr:id>52448C10-0507-400E-AEA5-D5EA670D4DDD</gtr:id><gtr:impact>Poster presentation, preliminary data for future grant application</gtr:impact><gtr:partnerContribution>Microbubble loading and manufacture was taught to us</gtr:partnerContribution><gtr:piContribution>This collaboration resulted in a poster presentation at a Microbubbles Conference in Leeds</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University College London (UCL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UCL School of Life and Medical Sciences</gtr:department><gtr:description>THIFU</gtr:description><gtr:id>C4703B46-623A-4ACE-B45C-25CF6E34690A</gtr:id><gtr:impact>See grant outputs</gtr:impact><gtr:partnerContribution>UCL were responsible for aspects of treatment planning</gtr:partnerContribution><gtr:piContribution>Collaborated on EPSRC funded grant</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Leeds</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Preparation of gadolinium microbubbles</gtr:description><gtr:id>87F98AB9-12C6-43B4-B59C-6C30645E324D</gtr:id><gtr:impact>Abstract at micro bubble symposium in Leeds</gtr:impact><gtr:partnerContribution>Development of methods of preparing and encapsulating contrast agents</gtr:partnerContribution><gtr:piContribution>We incorporated MR contrast agent in liposomes, following a method developed by our collaborators, monitoring them with MRI while irradiating them with HIFU</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Article for Pan-European networks</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>F464B645-9B50-4C03-ADAC-E06F5687A414</gtr:id><gtr:impact>Article just published. It is hoped it will stimulate pan-European research collaborations

Too early to tell yet</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>FUSF Centre of Excellence funding</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Focused Ultrasound Foundation</gtr:fundingOrg><gtr:id>7B4B5454-898B-4689-A370-D913FABBE5CD</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>393765</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Responsive mode grant MEK inhibition</gtr:description><gtr:end>2016-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K011057/1</gtr:fundingRef><gtr:id>D477B2B9-BC14-432C-BD74-96A5F3666D32</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>399246</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fellowship</gtr:description><gtr:end>2019-08-02</gtr:end><gtr:fundingOrg>Children with Cancer UK</gtr:fundingOrg><gtr:id>2379482D-8B0A-4330-9943-48A83A360E87</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>235864</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project Grant</gtr:description><gtr:end>2018-10-02</gtr:end><gtr:fundingOrg>Children with Cancer UK</gtr:fundingOrg><gtr:fundingRef>15-193</gtr:fundingRef><gtr:id>6CE5F706-73D7-4EE2-84D4-F8A3556E1683</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>450000</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>Focused Ultrasound Foundation's Centres of Excellence</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Focused Ultrasound Foundation</gtr:fundingOrg><gtr:id>9466B230-B5BA-44F5-9D68-A2298FB5E718</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1668000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>European Union EU Brussels</gtr:description><gtr:end>2015-04-02</gtr:end><gtr:fundingOrg>European Commission (EC)</gtr:fundingOrg><gtr:fundingRef>EMRP project HLT-03 - therapeutic ultrasound</gtr:fundingRef><gtr:id>6B4706A5-7B73-4E5A-81C9-EC30F7CC0644</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>242628</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>National Institute for Health Research (NIHR)</gtr:department><gtr:description>NIHR Research Fellowship (Post Doc)</gtr:description><gtr:end>2015-09-02</gtr:end><gtr:fundingOrg>University College London Hospitals Charity (UCLH)</gtr:fundingOrg><gtr:fundingRef>PDF-2012-05-441</gtr:fundingRef><gtr:id>A8161E75-0350-4CC4-B70C-7738191DEA2B</gtr:id><gtr:sector>Public</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>393765</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Evaluation of non-invasive metabolic imaging biomarkers for novel RAF/MEK1/2-targeted anti-cancer agents</gtr:description><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/K011057/1</gtr:fundingRef><gtr:id>7B78C2BA-2200-4F0A-980B-CD7CEAE309FD</gtr:id><gtr:sector>Academic/University</gtr:sector></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>10000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Centre for Cancer Imaging</gtr:description><gtr:end>2018-11-02</gtr:end><gtr:fundingOrg>Cancer Research UK (CRUK)</gtr:fundingOrg><gtr:id>4B905B70-2370-4517-B81D-E0E2924B97D2</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The main use of this grant has been to seed fund pilot studies. The use of these topics is therefore unclear as yet, until more extensive work has been undertaken</gtr:description><gtr:id>59D2CE90-791B-498C-B175-303F912A56EA</gtr:id><gtr:impactTypes><gtr:impactType>Societal</gtr:impactType></gtr:impactTypes><gtr:sector>Healthcare</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>This ongoing funding is still in its early stages. To date multi-disciplinary pilot projects on: 

i. Using Ultrasound Tracking to Improve Radiotherapy Precision

ii. Lactate as a non-invasive MRS imaging biomarker of response to BRAF

targeted therapeutics in BRAF driven melanoma

iii. Treatment planning for P-32 intra-cystic astrocytoma using multimodality

Imaging

iv. Whole body quantification of disease using PET and MRI

v. A pre-clinical study of Multi-modality 'dynamic contrast enhanced</gtr:description><gtr:exploitationPathways>As yet, none identified, although we have ongoing relationships with relevant companies which we will use. Where appropriate these pilot studies will form the basis for new grant applications.</gtr:exploitationPathways><gtr:id>26429187-43B1-4C9D-ADAC-0FA3CD2E37CC</gtr:id><gtr:sectors><gtr:sector>Healthcare</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Acquisition of tomographic ultrasound data including speed of sound, ultrasound transmission and ultrasound reflection data using a dedicated breast ultrasound tomography (UST) clinical device and a research device. Development of phantom to test 3D elastography implemented on UST. Software to analyse circumferential and radial motion in compressed tissues to determine elastic properties of tissues.</gtr:description><gtr:id>A7F2E79B-B96C-4FE2-BCF6-131FFC97FF4A</gtr:id><gtr:impact>The work is on-going. Further studies will be developed to increase sensitivity. Created new project collaboration with Karmonos Cancer Centre.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Acquisition of tomographic ultrasound data</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9EF55D6E-B14F-4886-B261-ABA4D326E26F"><gtr:id>9EF55D6E-B14F-4886-B261-ABA4D326E26F</gtr:id><gtr:title>SU-E-J-76: Incorporation of Ultrasound Elastography in Target Volume Delineation for Partial Breast Radiotherapy Planning: A Comparative Study</gtr:title><gtr:parentPublicationTitle>Medical Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ab2e8b4766f6d4320f7393680c595fc7"><gtr:id>ab2e8b4766f6d4320f7393680c595fc7</gtr:id><gtr:otherNames>Juneja P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B1B4582D-CFEA-4EED-A5DC-5A10B8EB10F6"><gtr:id>B1B4582D-CFEA-4EED-A5DC-5A10B8EB10F6</gtr:id><gtr:title>4D ultrasound speckle tracking of intra-fraction prostate motion: a phantom-based comparison with x-ray fiducial tracking using CyberKnife.</gtr:title><gtr:parentPublicationTitle>Physics in medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f87dcac022a25680212ac6f6d76175ba"><gtr:id>f87dcac022a25680212ac6f6d76175ba</gtr:id><gtr:otherNames>O'Shea TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0031-9155</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/714313FA-45C7-49C3-BD5D-EE9DC32A7792"><gtr:id>714313FA-45C7-49C3-BD5D-EE9DC32A7792</gtr:id><gtr:title>Real-Time Ultrasound Monitoring with Speckle Tracking in Abdominal Stereotactic Body Radiation Therapy</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/16c121382f6709092a03a017793856f8"><gtr:id>16c121382f6709092a03a017793856f8</gtr:id><gtr:otherNames>Su L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/59686DD6-8913-44B0-8018-DB3FABCD8919"><gtr:id>59686DD6-8913-44B0-8018-DB3FABCD8919</gtr:id><gtr:title>Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastoma.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/E3641AD4-3503-46D6-AC0F-C6A265B770A5"><gtr:id>E3641AD4-3503-46D6-AC0F-C6A265B770A5</gtr:id><gtr:title>Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumours.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2030b52e3d5b67bb4840aa02b60a83f"><gtr:id>e2030b52e3d5b67bb4840aa02b60a83f</gtr:id><gtr:otherNames>Denis-Bacelar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/5CF5790E-FCAE-49C1-8FDB-5BC6F27DF2A2"><gtr:id>5CF5790E-FCAE-49C1-8FDB-5BC6F27DF2A2</gtr:id><gtr:title>Tumour biomechanical response to the vascular disrupting agent ZD6126 in vivo assessed by magnetic resonance elastography.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad7968d586527c1fd3f76aeabf35ac38"><gtr:id>ad7968d586527c1fd3f76aeabf35ac38</gtr:id><gtr:otherNames>Li J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/71C14DDA-2C24-4AA7-A0E5-81F2F2A5B6E6"><gtr:id>71C14DDA-2C24-4AA7-A0E5-81F2F2A5B6E6</gtr:id><gtr:title>Intrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastoma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/82BE7ABF-4E09-4730-BD15-5FC913204CF3"><gtr:id>82BE7ABF-4E09-4730-BD15-5FC913204CF3</gtr:id><gtr:title>The Accuracy of Raw and B-Mode Image Data for Ultrasound Speckle Tracking in Radiation Therapy.</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/aeb0136b4d3fec6b6ac9a7b6feb9ee4c"><gtr:id>aeb0136b4d3fec6b6ac9a7b6feb9ee4c</gtr:id><gtr:otherNames>O'Shea T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F841FFD6-BF30-4BD6-9616-89D2D15FB2C3"><gtr:id>F841FFD6-BF30-4BD6-9616-89D2D15FB2C3</gtr:id><gtr:title>Measurement reproducibility of perfusion fraction and pseudodiffusion coefficient derived by intravoxel incoherent motion diffusion-weighted MR imaging in normal liver and metastases.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1a46550536f71ae0700d347b8e82974b"><gtr:id>1a46550536f71ae0700d347b8e82974b</gtr:id><gtr:otherNames>Andreou A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/90345923-E603-44FD-8CE3-3626184FAA03"><gtr:id>90345923-E603-44FD-8CE3-3626184FAA03</gtr:id><gtr:title>Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02ba091a36aebcaf23ad9fff21ea3847"><gtr:id>02ba091a36aebcaf23ad9fff21ea3847</gtr:id><gtr:otherNames>Blackledge MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9E925D8D-3EED-4239-9216-AA64187FC3D6"><gtr:id>9E925D8D-3EED-4239-9216-AA64187FC3D6</gtr:id><gtr:title>Model free approach to kinetic analysis of real-time hyperpolarized 13C magnetic resonance spectroscopy data.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/19f3af8ec08be99a9d9d8e56cecdc344"><gtr:id>19f3af8ec08be99a9d9d8e56cecdc344</gtr:id><gtr:otherNames>Hill DK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/CE00DD89-C779-4B5C-B305-6497AF18499A"><gtr:id>CE00DD89-C779-4B5C-B305-6497AF18499A</gtr:id><gtr:title>Small molecule inhibitors of aurora-a induce proteasomal degradation of N-myc in childhood neuroblastoma.</gtr:title><gtr:parentPublicationTitle>Cancer cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/0aa3ceb2de0f5d2f3c8253d6aef64e0a"><gtr:id>0aa3ceb2de0f5d2f3c8253d6aef64e0a</gtr:id><gtr:otherNames>Brockmann M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1535-6108</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/69B0A3F7-4017-4FE7-9250-2BB24095376F"><gtr:id>69B0A3F7-4017-4FE7-9250-2BB24095376F</gtr:id><gtr:title>Evaluating the diagnostic sensitivity of computed diffusion-weighted MR imaging in the detection of breast cancer.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3b4ad34e4c9c96a85aed0579b93e7397"><gtr:id>3b4ad34e4c9c96a85aed0579b93e7397</gtr:id><gtr:otherNames>O'Flynn EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/91A4F65A-D559-48E7-915A-F2095127BCA6"><gtr:id>91A4F65A-D559-48E7-915A-F2095127BCA6</gtr:id><gtr:title>First MRI application of an active breathing coordinator</gtr:title><gtr:parentPublicationTitle>Physics in Medicine and Biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a97b887e0b8ce0f868ad499ba7130038"><gtr:id>a97b887e0b8ce0f868ad499ba7130038</gtr:id><gtr:otherNames>Kaza, E</gtr:otherNames></gtr:author></gtr:authors></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84D57D8A-EA7D-4E0C-998E-120706205A99"><gtr:id>84D57D8A-EA7D-4E0C-998E-120706205A99</gtr:id><gtr:title>Volume of Bone Metastasis Assessed with Whole-Body Diffusion-weighted Imaging Is Associated with Overall Survival in Metastatic Castration-resistant Prostate Cancer.</gtr:title><gtr:parentPublicationTitle>Radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1c1ec776b27931eeb6292bb2a4ac43d7"><gtr:id>1c1ec776b27931eeb6292bb2a4ac43d7</gtr:id><gtr:otherNames>Perez-Lopez R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0033-8419</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F39F3D7A-4EDA-4E91-B233-C1E6D5F29148"><gtr:id>F39F3D7A-4EDA-4E91-B233-C1E6D5F29148</gtr:id><gtr:title>International consensus on use of focused ultrasound for painful bone metastases: Current status and future directions.</gtr:title><gtr:parentPublicationTitle>International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/9e15c333c2e3b2707b428a11cff6397c"><gtr:id>9e15c333c2e3b2707b428a11cff6397c</gtr:id><gtr:otherNames>Huisman M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0265-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A13AF94D-0372-41CE-94EA-50142E375D32"><gtr:id>A13AF94D-0372-41CE-94EA-50142E375D32</gtr:id><gtr:title>Lactate and choline metabolites detected in vitro by nuclear magnetic resonance spectroscopy are potential metabolic biomarkers for PI3K inhibition in pediatric glioblastoma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5bd49be1111a272266f27cf22fe474"><gtr:id>ed5bd49be1111a272266f27cf22fe474</gtr:id><gtr:otherNames>Al-Saffar NM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/368888F2-B008-4929-B0E2-E5939DB36FD1"><gtr:id>368888F2-B008-4929-B0E2-E5939DB36FD1</gtr:id><gtr:title>Detection of the prodrug-activating enzyme carboxypeptidase G2 activity with chemical exchange saturation transfer magnetic resonance.</gtr:title><gtr:parentPublicationTitle>Molecular imaging and biology : MIB : the official publication of the Academy of Molecular Imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1536-1632</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D7515969-3CE5-4C63-96CB-116570E77F28"><gtr:id>D7515969-3CE5-4C63-96CB-116570E77F28</gtr:id><gtr:title>A study of thermal dose-induced autophagy, apoptosis and necroptosis in colon cancer cells.</gtr:title><gtr:parentPublicationTitle>International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bb9eabb81977d23c733707929677b4da"><gtr:id>bb9eabb81977d23c733707929677b4da</gtr:id><gtr:otherNames>Mouratidis PX</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0265-6736</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/993C9274-B9D9-4E27-83FD-BBEE62297148"><gtr:id>993C9274-B9D9-4E27-83FD-BBEE62297148</gtr:id><gtr:title>Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.</gtr:title><gtr:parentPublicationTitle>European radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/59e33e0b795c8d66c718228a3e4069ba"><gtr:id>59e33e0b795c8d66c718228a3e4069ba</gtr:id><gtr:otherNames>Rata M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0938-7994</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/068C3140-48B1-4E96-BF10-21A8D07C4268"><gtr:id>068C3140-48B1-4E96-BF10-21A8D07C4268</gtr:id><gtr:title>Cyclin-Dependent Kinase Inhibitor AT7519 as a Potential Drug for MYCN-Dependent Neuroblastoma.</gtr:title><gtr:parentPublicationTitle>Clinical cancer research : an official journal of the American Association for Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8952a6df018f73e95bfc103ab62d8f0c"><gtr:id>8952a6df018f73e95bfc103ab62d8f0c</gtr:id><gtr:otherNames>Dolman ME</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1078-0432</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/547B064C-C62D-4DC2-842A-2ACBD8E51C93"><gtr:id>547B064C-C62D-4DC2-842A-2ACBD8E51C93</gtr:id><gtr:title>Efficient [(18)F]AlF Radiolabeling of ZHER3:8698 Affibody Molecule for Imaging of HER3 Positive Tumors.</gtr:title><gtr:parentPublicationTitle>Bioconjugate chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/6292a0d77b59ab1b03b73d440a569551"><gtr:id>6292a0d77b59ab1b03b73d440a569551</gtr:id><gtr:otherNames>Da Pieve C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1043-1802</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BAE4A748-CDF6-45D3-9D83-C63789F77F70"><gtr:id>BAE4A748-CDF6-45D3-9D83-C63789F77F70</gtr:id><gtr:title>Classification of fibroglandular tissue distribution in the breast based on radiotherapy planning CT.</gtr:title><gtr:parentPublicationTitle>BMC medical imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ab2e8b4766f6d4320f7393680c595fc7"><gtr:id>ab2e8b4766f6d4320f7393680c595fc7</gtr:id><gtr:otherNames>Juneja P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2342</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/724F483A-D383-45D1-B9E3-3FF5A0D04F11"><gtr:id>724F483A-D383-45D1-B9E3-3FF5A0D04F11</gtr:id><gtr:title>Image guided prostate radiotherapy using cyberknife: a preliminary comparison with 4d ultrasound</gtr:title><gtr:parentPublicationTitle>Proceedings of the International Tissue Elasticity Conference</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/55de6220c8220f40a76a2b3ce82927d1"><gtr:id>55de6220c8220f40a76a2b3ce82927d1</gtr:id><gtr:otherNames>Garcia L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2AFA911D-CB3B-40DE-A3B3-A2A71BA9125B"><gtr:id>2AFA911D-CB3B-40DE-A3B3-A2A71BA9125B</gtr:id><gtr:title>Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FB207521-BB60-4053-A100-C21D3C585D95"><gtr:id>FB207521-BB60-4053-A100-C21D3C585D95</gtr:id><gtr:title>Tissue motion assessment and biomechanical property imaging update (invited short-course)</gtr:title><gtr:parentPublicationTitle>Proc. IEEE International Ultrasonics Symposium</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/853b54f0ecf2c780ab3276cdac78b47d"><gtr:id>853b54f0ecf2c780ab3276cdac78b47d</gtr:id><gtr:otherNames>Bamber JC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0B512837-0CFC-45ED-98AA-8F9234B56806"><gtr:id>0B512837-0CFC-45ED-98AA-8F9234B56806</gtr:id><gtr:title>Ultrasound elastography superior to MRI for intraoperative identification of epileptogenic foci. Abstract ID: 1178</gtr:title><gtr:parentPublicationTitle>British Journal of Neurosurgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/17010f2134893643ee975c3fe0f62d06"><gtr:id>17010f2134893643ee975c3fe0f62d06</gtr:id><gtr:otherNames>Chan HW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7B2BF81E-AA74-44D9-B350-E91586D636D7"><gtr:id>7B2BF81E-AA74-44D9-B350-E91586D636D7</gtr:id><gtr:title>Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/924E4576-05D8-411D-B018-50D497489594"><gtr:id>924E4576-05D8-411D-B018-50D497489594</gtr:id><gtr:title>MO-DE-210-05: Improved Accuracy of Liver Feature Motion Estimation in B-Mode Ultrasound for Image-Guided Radiation Therapy</gtr:title><gtr:parentPublicationTitle>Medical Physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/2441e10bca364e0a8b21d0fe3fbbb8e0"><gtr:id>2441e10bca364e0a8b21d0fe3fbbb8e0</gtr:id><gtr:otherNames>O'shea T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/25E09413-250A-4AB6-96D5-EC9CC0E0D0E4"><gtr:id>25E09413-250A-4AB6-96D5-EC9CC0E0D0E4</gtr:id><gtr:title>Patient-specific dosimetry for intracavitary 32P-chromic phosphate colloid therapy of cystic brain tumours.</gtr:title><gtr:parentPublicationTitle>European journal of nuclear medicine and molecular imaging</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e2030b52e3d5b67bb4840aa02b60a83f"><gtr:id>e2030b52e3d5b67bb4840aa02b60a83f</gtr:id><gtr:otherNames>Denis-Bacelar AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1619-7070</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/24ACA9F7-2E34-4619-AA80-F877D5575B49"><gtr:id>24ACA9F7-2E34-4619-AA80-F877D5575B49</gtr:id><gtr:title>Body Diffusion-weighted MR Imaging in Oncology: Imaging at 3 T.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance imaging clinics of North America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7cb2b530ca6d8d3f3ecd9b026b702cd6"><gtr:id>7cb2b530ca6d8d3f3ecd9b026b702cd6</gtr:id><gtr:otherNames>Koh DM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1064-9689</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A9BFB987-529B-4C33-BE44-5F5EB6149277"><gtr:id>A9BFB987-529B-4C33-BE44-5F5EB6149277</gtr:id><gtr:title>Breast density measurements with ultrasound tomography: a comparison with non-contrast MRI</gtr:title><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3ab76e581378a16fb41f30ea30fbfc9c"><gtr:id>3ab76e581378a16fb41f30ea30fbfc9c</gtr:id><gtr:otherNames>O'Flynn E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DE206822-4029-43A1-801C-76ED025EA966"><gtr:id>DE206822-4029-43A1-801C-76ED025EA966</gtr:id><gtr:title>The utility of whole-body diffusion-weighted MRI for delineating regions of interest in PET</gtr:title><gtr:parentPublicationTitle>Nuclear Instruments and Methods in Physics Research Section A: Accelerators, Spectrometers, Detectors and Associated Equipment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/74202e8f8cc181a02b001f7ddacb5680"><gtr:id>74202e8f8cc181a02b001f7ddacb5680</gtr:id><gtr:otherNames>Blackledge M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4FE6F5EB-283C-4CCF-8F9E-ACAC3B688528"><gtr:id>4FE6F5EB-283C-4CCF-8F9E-ACAC3B688528</gtr:id><gtr:title>Dichloroacetate induces autophagy in colorectal cancer cells and tumours.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34cf073710acda1f00a6fbaba4e34e9b"><gtr:id>34cf073710acda1f00a6fbaba4e34e9b</gtr:id><gtr:otherNames>Lin G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DB0EB0DC-7151-44D4-9956-D1C19A00B379"><gtr:id>DB0EB0DC-7151-44D4-9956-D1C19A00B379</gtr:id><gtr:title>Response evaluation in mesothelioma: Beyond RECIST.</gtr:title><gtr:parentPublicationTitle>Lung cancer (Amsterdam, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/4237895ca8106ea327b568d11d28f8c7"><gtr:id>4237895ca8106ea327b568d11d28f8c7</gtr:id><gtr:otherNames>Cheng L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0169-5002</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4C70CE8B-496C-4793-8F55-CE783693CFA6"><gtr:id>4C70CE8B-496C-4793-8F55-CE783693CFA6</gtr:id><gtr:title>MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fb04c5389bbd9ce35eb2c016f425f321"><gtr:id>fb04c5389bbd9ce35eb2c016f425f321</gtr:id><gtr:otherNames>Falck Miniotis M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F4E89FB-C59C-4931-81B2-4E11AB9A95E6"><gtr:id>0F4E89FB-C59C-4931-81B2-4E11AB9A95E6</gtr:id><gtr:title>Evaluation and immunohistochemical qualification of carbogen-induced ?R2 as a noninvasive imaging biomarker of improved tumor oxygenation.</gtr:title><gtr:parentPublicationTitle>International journal of radiation oncology, biology, physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/e6edb6fd2930bc14d67152e5bab5e4ff"><gtr:id>e6edb6fd2930bc14d67152e5bab5e4ff</gtr:id><gtr:otherNames>Baker LC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0360-3016</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DD048FD1-F1D1-4337-B122-B37F041B8D28"><gtr:id>DD048FD1-F1D1-4337-B122-B37F041B8D28</gtr:id><gtr:title>Exploring the biomechanical properties of brain malignancies and their pathologic determinants in vivo with magnetic resonance elastography.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d18d86167a18513bde160839c292ff54"><gtr:id>d18d86167a18513bde160839c292ff54</gtr:id><gtr:otherNames>Jamin Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AEED3060-8900-4C0D-A782-DA2E000346D7"><gtr:id>AEED3060-8900-4C0D-A782-DA2E000346D7</gtr:id><gtr:title>Abstract 1488:
 
 magnetic resonance elastography in pediatric brain tumor models</gtr:title><gtr:parentPublicationTitle>Cancer Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ad7968d586527c1fd3f76aeabf35ac38"><gtr:id>ad7968d586527c1fd3f76aeabf35ac38</gtr:id><gtr:otherNames>Li J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/31602521-966E-47E5-AE50-43A6AA2F94B5"><gtr:id>31602521-966E-47E5-AE50-43A6AA2F94B5</gtr:id><gtr:title>Exploring ?R(2) * and ?R(1) as imaging biomarkers of tumor oxygenation.</gtr:title><gtr:parentPublicationTitle>Journal of magnetic resonance imaging : JMRI</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/c41b8d059958eda786b850b7642d33b3"><gtr:id>c41b8d059958eda786b850b7642d33b3</gtr:id><gtr:otherNames>Burrell JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1053-1807</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C4285925-2041-40E2-B552-FC0135CF3947"><gtr:id>C4285925-2041-40E2-B552-FC0135CF3947</gtr:id><gtr:title>Reduced Warburg effect in cancer cells undergoing autophagy: steady- state 1H-MRS and real-time hyperpolarized 13C-MRS studies.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/34cf073710acda1f00a6fbaba4e34e9b"><gtr:id>34cf073710acda1f00a6fbaba4e34e9b</gtr:id><gtr:otherNames>Lin G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/FC675999-227E-4632-AEE0-15A44FBF07D0"><gtr:id>FC675999-227E-4632-AEE0-15A44FBF07D0</gtr:id><gtr:title>Rapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX.</gtr:title><gtr:parentPublicationTitle>Computers in biology and medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/02ba091a36aebcaf23ad9fff21ea3847"><gtr:id>02ba091a36aebcaf23ad9fff21ea3847</gtr:id><gtr:otherNames>Blackledge MD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0010-4825</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C531AA41-0412-440A-8C09-025465E673EE"><gtr:id>C531AA41-0412-440A-8C09-025465E673EE</gtr:id><gtr:title>Diffusion-weighted MRI for imaging cell death after cytotoxic or apoptosis-inducing therapy.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3e93b933b0f0eb88f11d85ccab658159"><gtr:id>3e93b933b0f0eb88f11d85ccab658159</gtr:id><gtr:otherNames>Papaevangelou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/02ED1CCF-317F-4047-9243-DAF14021D89B"><gtr:id>02ED1CCF-317F-4047-9243-DAF14021D89B</gtr:id><gtr:title>Temporal regularization of ultrasound-based liver motion estimation for image-guided radiation therapy.</gtr:title><gtr:parentPublicationTitle>Medical physics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f87dcac022a25680212ac6f6d76175ba"><gtr:id>f87dcac022a25680212ac6f6d76175ba</gtr:id><gtr:otherNames>O'Shea TP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0094-2405</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/H046526/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>6723A70B-A523-40AB-9740-B6AD2A0677B7</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Medical &amp; health interface</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>16595C3C-600D-4AD2-B394-16E06F96495F</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Med.Instrument.Device&amp; Equip.</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>